The phrase "a more effective regimen" is correct and usable in written English.
You can use it when discussing improvements or enhancements to a plan or routine, particularly in contexts like health, fitness, or treatment.
Example: "After reviewing the results, we decided to implement a more effective regimen for our training program."
Alternatives: "a better plan" or "an improved routine."
Knowledge of the mechanism by which arsenic trioxide exerts the anti-tumor effects may help in designing a more effective regimen for therapy.
That first exciting result compared Avastin with a type of chemotherapy that has since been widely replaced by a more effective regimen.
Therefore, a more effective regimen should be used to improve the survival of non-GCB subtype DLBCL patients.
The present study was designed to test whether the combination of cisplatin and irinotecan with ifosfamide can develop a more effective regimen.
Although the study by Nordlinger et al. [ 15] included more patients than the previously reported pooled analysis by Mitry et al. [ 14] and employed a more effective regimen, we found no evidence of study heterogeneity in relation to the graphical or statistical methods within the systemic therapy group.
In order to develop a more effective regimen, studies have been conducted in which the dose intensity of irinotecan and/or cisplatin has been increased (Masuda et al, 1994; Kobayashi et al, 1998; Ueoka et al, 2001), and in which various triplet-drug combination therapies using irinotecan, cisplatin, and another drug have been explored (Shinkai et al, 1994).
With the breakthroughs of a rapid test for second-line drug resistance and a shorter, more effective, regimen, we may be at a turning point in our efforts to tackle drug-resistant forms of TB.
Results from this trial indicated that the 150 mg/m qw 3/4 dose of nab-paclitaxel was a significantly more effective regimen than docetaxel [ 13].
This could spare patients toxicity of non-efficacious therapy, and allow revision to a potentially more effective regimen in patients who are destined to respond poorly to the initial treatment.
Prognostic parameters (pT and pN) and only marginally HER2 were the principal determinants for the prescription of the type of chemotherapy, with the use of more effective regimen (anthracyclines and taxanes) with increasing risk recurrence and HER2-positive.
We anticipate further refinement of these favorable results in the future via the decreased extramedullary side effects of TMI, a more effective GVHD regimen and the selection of AML patients most likely to benefit from this protocol.
